Theranos phenomenon: promises and fallacies.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Works matching Theranos
Results: 71
1
2
Startup Ethics: Ethically Responsible Conduct of Scientists and Engineers at Theranos.
- Published in:
- Science & Engineering Ethics, 2022, v. 28, n. 5, p. 1, doi. 10.1007/s11948-022-00393-2
- By:
- Publication type:
- Article
3
Lessons from Theranos – Restructuring Biomedical Innovation.
- Published in:
- Journal of Medical Systems, 2022, v. 46, n. 5, p. 1, doi. 10.1007/s10916-022-01813-3
- By:
- Publication type:
- Article
4
Bad Witches: Gender and the Downfall of Elizabeth Holmes of Theranos and Disney's Maleficent.
- Published in:
- Social Sciences (2076-0760), 2019, v. 8, n. 6, p. 175, doi. 10.3390/socsci8060175
- By:
- Publication type:
- Article
5
Theranos phenomenon - part 3.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 5, p. e145, doi. 10.1515/cclm-2016-0107
- By:
- Publication type:
- Article
6
Theranos phenomenon - part 2.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
7
Despotic Leadership and Ideological Manipulation at Theranos: Towards a theory of hegemonic totalism in the workplace.
- Published in:
- Organization Studies, 2023, v. 44, n. 11, p. 1801, doi. 10.1177/01708406231171801
- By:
- Publication type:
- Article
8
Evaluating and using innovative technologies: a lesson from Theranos?
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2015, v. 53, n. 7, p. 961, doi. 10.1515/cclm-2015-0411
- By:
- Publication type:
- Article
9
Will Theranos Perform a Pilot Study and Publish Their Results?
- Published in:
- Canadian Journal of Pathology, 2015, v. 7, n. 3, p. 4
- By:
- Publication type:
- Article
10
The meteoric rise and dramatic fall of Theranos: lessons learned for the diagnostic industry.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 9, p. 1443, doi. 10.1515/cclm-2018-0353
- By:
- Publication type:
- Article
11
Theranos phenomenon - Part 5: Theranos' presentation at the American Association for Clinical Chemistry Annual Conference 2016.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 10, p. e313, doi. 10.1515/cclm-2016-0737
- By:
- Publication type:
- Article
12
Theranos phenomenon -- part 4: Theranos at an International Conference.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 8, p. e243, doi. 10.1515/cclm-2016-0389
- By:
- Publication type:
- Article
13
Theranos: Almost Complete Absence of Laboratory Medicine Input.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
14
Theranos Session at the 2016 AACC Annual Scientific Meeting & Clinical Lab Expo: Expectations, Impressions, and Takeaways.
- Published in:
- Journal of Applied Laboratory Medicine, 2016, p. 329, doi. 10.1373/jalm.2016.021709
- By:
- Publication type:
- Article
15
Stealth Research and Theranos: Reflections and Update 1 Year Later.
- Published in:
- 2016
- By:
- Publication type:
- journal article
16
Theranos, ¿el unicornio que colapsa?
- Published in:
- IEEM Revista de Negocios, 2016, v. 19, n. 4, p. 70
- By:
- Publication type:
- Article
17
Theranos revisited: the trial and lessons learned.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
18
The Theranos saga and the consequences.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 9, p. 1395, doi. 10.1515/cclm-2018-0392
- By:
- Publication type:
- Article
19
The Theranos phenomenon, scientific transparency and freedom of speech.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 9, p. 1403, doi. 10.1515/cclm-2016-0520
- By:
- Publication type:
- Article
20
THERANOS: CAUTIONARY TALE OF ETHICAL FAILINGS.
- Published in:
- Strategic Finance, 2022, v. 103, n. 12, p. 13
- By:
- Publication type:
- Article
21
Theranos: What did analytical chemists have to say about the hype?
- Published in:
- Journal of Separation Science, 2019, v. 42, n. 11, p. 1960, doi. 10.1002/jssc.201900431
- By:
- Publication type:
- Article
22
Theranos makes its case at AACC.
- Published in:
- Medical Laboratory Observer (MLO), 2016, v. 48, n. 9, p. 4
- By:
- Publication type:
- Article
23
After Theranos: Using point‐of‐care testing to advance measures of health biomarkers in human biology research.
- Published in:
- American Journal of Human Biology, 2022, v. 34, n. 11, p. 1, doi. 10.1002/ajhb.23689
- By:
- Publication type:
- Article
24
Theranos Verdict: In the U.S., It Is Fine to Lie to Consumers but Not to Investors.
- Published in:
- CounterPunch, 2022, p. 1
- By:
- Publication type:
- Article
25
"The Good, the Bad, the Ugly": Leadership Lessons From two Companies - Amgen and Theranos.
- Published in:
- Journal of Commercial Biotechnology, 2019, v. 24, n. 4, p. 67, doi. 10.5912/jcb918
- By:
- Publication type:
- Article
26
TEACHING THERANOS.
- Published in:
- Tennessee Law Review, 2022, v. 90, n. 1, p. 63
- By:
- Publication type:
- Article
27
Theranos and the Tale of the Disappearing Board of Directors.
- Published in:
- Advocate (05154987), 2020, v. 63, n. 3/4, p. 10
- By:
- Publication type:
- Article
28
HOW AND WHY DID IT GO SO WRONG?: THERANOS AS A LEGAL ETHICS CASE STUDY.
- Published in:
- Georgia State University Law Review, 2021, v. 37, n. 2, p. 427
- By:
- Publication type:
- Article
29
The Bleeding Edge: Theranos and the Growing Risk of an Unregulated Private Securities Market.
- Published in:
- University of Miami Business Law Review, 2020, v. 28, n. 2, p. 404
- By:
- Publication type:
- Article
30
The post-Theranos world.
- Published in:
- 2022
- Publication type:
- Editorial
31
Microfluidics in the marketplace: Theranos makes its move.
- Published in:
- Medical Laboratory Observer (MLO), 2015, v. 47, n. 6, p. 4
- By:
- Publication type:
- Article
32
Will Theranos Take the Challenge of Performing a Pilot Study and Publishing Their Results?
- Published in:
- Canadian Journal of Pathology, 2016, v. 8, n. 1, p. 7
- By:
- Publication type:
- Article
33
Governance basics for the physician-scientist considering business ventures. Lessons from Theranos.
- Published in:
- Discover Health Systems, 2023, v. 2, n. 1, p. 1, doi. 10.1007/s44250-023-00045-7
- By:
- Publication type:
- Article
34
Theranos Lessons: Déjà Vu All Over Again?
- Published in:
- Clinical Leadership & Management Review, 2017, v. 31, n. 1, p. 26
- By:
- Publication type:
- Article
35
Please do not call it Theranos.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 7, p. e103, doi. 10.1515/cclm-2023-0110
- By:
- Publication type:
- Article
36
If Theranos' Tests Had Actually Worked.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
37
After Theranos.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 1, p. 11, doi. 10.1038/nbt.3761
- By:
- Publication type:
- Article
38
Theranos Experience Exposes Weaknesses in FDA Regulatory Discretion.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 433, doi. 10.1002/cpdd.374
- By:
- Publication type:
- Article
39
THE HISTORY OF THERANOS AND THE LESSONS LEARNED FROM A DROP OF BLOOD.
- Published in:
- 2019
- By:
- Publication type:
- Book Review
40
Elizabeth Holmes: Silicon Valley, unicorns, and the limits of visibility.
- Published in:
- Feminist Media Studies, 2024, v. 24, n. 7, p. 1567, doi. 10.1080/14680777.2023.2245979
- By:
- Publication type:
- Article
41
Technology-driven diagnostics: From smart doctor to smartphone.
- Published in:
- Critical Reviews in Clinical Laboratory Sciences, 2016, v. 53, n. 4, p. 268, doi. 10.3109/10408363.2016.1149689
- By:
- Publication type:
- Article
42
Against 'instantaneous' expertise.
- Published in:
- 2022
- By:
- Publication type:
- journal article
43
Burst bubbles.
- Published in:
- 2015
- Publication type:
- Editorial
44
The $9 Herpes Test.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 314, n. 7, p. 662, doi. 10.1001/jama.2015.9405
- By:
- Publication type:
- Article
45
Stealth Research.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 7, p. 663
- By:
- Publication type:
- Article
46
John Carreyrou, Bad Blood: Secrets and Lies in a Silicon Valley Startup, Picador, 2018, ISBN 978-1-5098-6808-7, pb, 339pp, incl index, $A18.99.
- Published in:
- 2019
- By:
- Publication type:
- Book Review
47
BAD BLOOD: SECRETS AND LIES IN A SILICON VALLEY STARTUP: John Carreyrou New York, NY: Knopf Doubleday Publishing. 2020. 400 pp. ISBN 978-0525431992. List price: $18.00. Paperback.
- Published in:
- 2024
- By:
- Publication type:
- Book Review
48
The Rise of Consumer-Based Blood Testing: A Huge Step Forward for the Exercise Physiologist.
- Published in:
- Professionalization of Exercise Physiology, 2017, v. 20, n. 2, p. 1
- By:
- Publication type:
- Article
49
Bad blood: secrets and lies in a silicon valley startup by John Carreyrou: Book Review.
- Published in:
- 2021
- By:
- Publication type:
- Book Review
50
Silicon Valley Fake: Elizabeth Holmes and the Fraudster's Motivation.
- Published in:
- CounterPunch, 2022, p. 1
- By:
- Publication type:
- Article